Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Co-codamol 15/500mg Capsules vs 30/500mg Tablets
NCT03280095Phase 1Completed
- Sponsor
- Galen
- Start
- Sep 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Paracetamol + codeine in pain (3 arms), sponsored by Galen. Primary endpoints: Maximum measurable plasma concentration and Area under the plasma concentration versus time curve from drug administration to last observed concentration. Started Sep 2014; status: completed.
02
Drugs
Paracetamol + codeine
03
Conditions
pain
Beyond the preview
Go deeper on NCT03280095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03280095.